Germline mutations in MSH2 and MLH1 together account for nearly half of all hereditary non-polyposis colorectal cancer (HNPCC) patients, of which ∼60% of the mutations are in the MLH1 gene, and ∼35% in the MSH2 gene [49]. This evidence concerns the gene MSH2 and hereditary nonpolyposis colon cancer.